Ocular Therapeutix OCUL Current ratio

Current ratio at other companies

Regeneron PharmaceuticalsREGN

3.3×-1.3×

EyePoint, Inc.EYPT

4.5×-3.5×

KLR

Kalaris TherapeuticsKLRS

12.2×-2.1×

Bausch + LombBLCO

1.5×0.0×

HRO

HarrowHROW

2.5×+1.6×

Tarsus Pharmaceuticals, Inc.TARS

3.2×-2.1×

FAQ

What is Ocular Therapeutix's current ratio?

Ocular Therapeutix (OCUL) reported current ratio of 14.8× in Q1 2026.

How has Ocular Therapeutix's current ratio changed year-over-year?

Ocular Therapeutix's current ratio increased by 44.8% year-over-year, from 10.2× to 14.8×.

What is the long-term trend for Ocular Therapeutix's current ratio?

Over 5 years (2020 to 2025), Ocular Therapeutix's current ratio has grown at a 10.8% compound annual growth rate (CAGR), from 9.2× to 15.4×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.